ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04120	Ubiquitin mediated proteolysis	5/48	138/7206	0.00211727931182
ko04151	PI3K-Akt signaling pathway	8/48	390/7206	0.00383766978401
ko00623	Toluene degradation	1/48	1/7206	0.0066611157369
ko00361	Chlorocyclohexane and chlorobenzene degradation	1/48	1/7206	0.0066611157369
ko00364	Fluorobenzoate degradation	1/48	1/7206	0.0066611157369
ko05162	Measles	4/48	120/7206	0.00809266023419
ko00531	Glycosaminoglycan degradation	2/48	23/7206	0.01005528557
ko00511	Other glycan degradation	2/48	26/7206	0.0127541881958
ko00073	Cutin, suberine and wax biosynthesis	1/48	2/7206	0.0132787793657
ko04320	Dorso-ventral axis formation	2/48	31/7206	0.0178675481624
ko05160	Hepatitis C	4/48	153/7206	0.018437756122
ko05218	Melanoma	3/48	85/7206	0.0187081555767
ko00780	Biotin metabolism	1/48	3/7206	0.0198532683425
ko05161	Hepatitis B	4/48	173/7206	0.02750088164
ko05224	Breast cancer	4/48	174/7206	0.0280131075411
ko04217	Necroptosis	4/48	178/7206	0.0301193705337
ko05219	Bladder cancer	2/48	48/7206	0.0403592347311
ko04668	TNF signaling pathway	3/48	120/7206	0.0452985975176
ko04261	Adrenergic signaling in cardiomyocytes	4/48	205/7206	0.0467710627955
ko01522	Endocrine resistance	3/48	124/7206	0.0491164534616